Skip to main content
Top
Published in: BMC Nephrology 1/2023

Open Access 01-12-2023 | Thrombosis | Research

Improving assessment and escalation of threatened haemodialysis access: results of a nursing-led program

Authors: Dana Forcey, Dan Tran, Jenny Connor, Piriya Kusuma Na Ayudhya, Christian Ocampo, Craig Nelson, Sandra Crikis

Published in: BMC Nephrology | Issue 1/2023

Login to get access

Abstract

Background

Optimal vascular access is critical to successful haemodialysis. Acute thrombosis of haemodialysis access often leads to unplanned hospital admissions and interventions to restore patency.
Western Health is a large health service in Victoria, Australia. During the period February 2019 to January 2020, the rate of arteriovenous fistula (AVF) and arteriovenous graft (AVG) at Western Health satellite dialysis units was 0.33 episodes per 1000 patient-days, higher than the reported rate in the literature of 0.24 events per 1000 patient-days, and was associated with a cumulative total of 139 days of inpatient stay (2.2 per 1000 patient-days).

Methods

The above results prompted creation of an education and escalation pathway for threatened haemodialysis access, based upon clinical markers of vascular access stenosis or imminent thrombosis assessed by nursing staff in satellite haemodialysis centres.
In the period February 2020 to January 2021, the education and escalation pathway was implemented. We assessed referrals via the pathway, rates of AVF/AVG thrombosis and associated hospital length of stay in the following 12-month period (February 2021 to January 2022).

Results

Following introduction of the pathway, rates of AVF/AVG thrombosis declined to 0.15 per 1000 patient-days (p = 0.02), associated with a decline in attributable cumulative inpatient stay to 55 days (0.69 per 1000 patient-days).

Conclusions

Our program demonstrates that the majority of thrombosed vascular access can be predicted and potentially averted with vigilant and well-practiced routine clinical assessment by trained nursing staff. Our nursing-led education and escalation program successfully identified vascular access at risk of imminent thrombosis, reduced rates of acute thrombosis and associated healthcare costs.
Despite these improvements, there are still disparities in outcomes for patients with thrombosed vascular access, with regards to length of stay and requirement for insertion of a temporary central venous catheter (CVC) for urgent dialysis whilst awaiting intervention, and these are areas for further investigation and improvement.
Literature
1.
go back to reference Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4):S1–164.CrossRefPubMed Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis. 2020;75(4):S1–164.CrossRefPubMed
2.
go back to reference Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465–73.CrossRefPubMedPubMedCentral Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465–73.CrossRefPubMedPubMedCentral
3.
go back to reference Kasza J, Wolfe R, McDonald SP, Marshall MR, Polkinghorne KR. Dialysis modality, vascular access and mortality in end-stage kidney disease: A bi-national registry-based cohort study. Nephrology. 2016;21(10):878–86.CrossRefPubMed Kasza J, Wolfe R, McDonald SP, Marshall MR, Polkinghorne KR. Dialysis modality, vascular access and mortality in end-stage kidney disease: A bi-national registry-based cohort study. Nephrology. 2016;21(10):878–86.CrossRefPubMed
4.
go back to reference Dhingra RK, Young EW, Hulbert-Shearon T, Leavey SF, Port FK. Type of vascular access and mortality in US hemodialysis patients. Kidney Int. 2001;60(4):1443–51.CrossRefPubMed Dhingra RK, Young EW, Hulbert-Shearon T, Leavey SF, Port FK. Type of vascular access and mortality in US hemodialysis patients. Kidney Int. 2001;60(4):1443–51.CrossRefPubMed
5.
go back to reference Al-Jaishi AA, Liu AR, Lok CE, Zhang JC, Moist LM. Complications of the arteriovenous fistula: a systematic review. J Am Soc Nephrol. 2017;28(6):1839–50.CrossRefPubMed Al-Jaishi AA, Liu AR, Lok CE, Zhang JC, Moist LM. Complications of the arteriovenous fistula: a systematic review. J Am Soc Nephrol. 2017;28(6):1839–50.CrossRefPubMed
6.
go back to reference Girerd S, Girerd N, Frimat L, Holdaas H, Jardine AG, Schmieder RE, et al. Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial. Clin Kidney J. 2020;13(1):116–22.CrossRefPubMed Girerd S, Girerd N, Frimat L, Holdaas H, Jardine AG, Schmieder RE, et al. Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial. Clin Kidney J. 2020;13(1):116–22.CrossRefPubMed
7.
go back to reference Thomas M, Nesbitt C, Ghouri M, Hansrani M. Maintenance of hemodialysis vascular access and prevention of access dysfunction: a review. Ann Vasc Surg. 2017;43:318–27.CrossRefPubMed Thomas M, Nesbitt C, Ghouri M, Hansrani M. Maintenance of hemodialysis vascular access and prevention of access dysfunction: a review. Ann Vasc Surg. 2017;43:318–27.CrossRefPubMed
8.
go back to reference Aragoncillo I, Amézquita Y, Caldés S, Abad S, Vega A, Cirugeda A, et al. The impact of access blood flow surveillance on reduction of thrombosis in native arteriovenous fistula: a randomized clinical trial. J Vasc Access. 2016;17(1):13–9.CrossRefPubMed Aragoncillo I, Amézquita Y, Caldés S, Abad S, Vega A, Cirugeda A, et al. The impact of access blood flow surveillance on reduction of thrombosis in native arteriovenous fistula: a randomized clinical trial. J Vasc Access. 2016;17(1):13–9.CrossRefPubMed
9.
10.
go back to reference Kanbay M, Ertuglu LA, Afsar B, Ozdogan E, Siriopol D, Covic A, et al. An update review of intradialytic hypotension: concept, risk factors, clinical implications and management. Clin Kidney J. 2020;13(6):981–93.CrossRefPubMedPubMedCentral Kanbay M, Ertuglu LA, Afsar B, Ozdogan E, Siriopol D, Covic A, et al. An update review of intradialytic hypotension: concept, risk factors, clinical implications and management. Clin Kidney J. 2020;13(6):981–93.CrossRefPubMedPubMedCentral
11.
go back to reference Lee Y-N, Kim EY. Experiences of Nurses Caring for Hemodialysis Patients: A Qualitative Meta-Synthesis Study. Korean J Adult Nurs. 2022;34(2):168–77.CrossRef Lee Y-N, Kim EY. Experiences of Nurses Caring for Hemodialysis Patients: A Qualitative Meta-Synthesis Study. Korean J Adult Nurs. 2022;34(2):168–77.CrossRef
12.
go back to reference Wright SM. Using Evidence-Based Practice and an Educational Intervention to Improve Vascular Access Management: A Pilot Project. Nephrology Nursing Journal. 2017;44(5). Wright SM. Using Evidence-Based Practice and an Educational Intervention to Improve Vascular Access Management: A Pilot Project. Nephrology Nursing Journal. 2017;44(5).
13.
go back to reference Martinez-Smith Y, Meek C, Tranter S. The impact of a dedicated renal vascular access nurse on haemodialysis access outcomes. Vascular Access. 2016;2(1):10–6. Martinez-Smith Y, Meek C, Tranter S. The impact of a dedicated renal vascular access nurse on haemodialysis access outcomes. Vascular Access. 2016;2(1):10–6.
14.
go back to reference Chang TI, Paik J, Greene T, Desai M, Bech F, Cheung AK, et al. Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol. 2011;22(8):1526.CrossRefPubMedPubMedCentral Chang TI, Paik J, Greene T, Desai M, Bech F, Cheung AK, et al. Intradialytic hypotension and vascular access thrombosis. J Am Soc Nephrol. 2011;22(8):1526.CrossRefPubMedPubMedCentral
Metadata
Title
Improving assessment and escalation of threatened haemodialysis access: results of a nursing-led program
Authors
Dana Forcey
Dan Tran
Jenny Connor
Piriya Kusuma Na Ayudhya
Christian Ocampo
Craig Nelson
Sandra Crikis
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2023
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-023-03321-z

Other articles of this Issue 1/2023

BMC Nephrology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine